AOD-9604 in El Chocolate — Fat Loss Peptide Research Guide
AOD-9604 research guide for El Chocolate. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.
AOD-9604 in El Chocolate: Sourcing, Purity & Protocols
AOD-9604 won't be found on pharmacy shelves in El Chocolate or most other cities — this is a specialist compound distributed through a dedicated online market. What this means for El Chocolate researchers is that your location matters far less than your ability to assess COA data — and those quality checks are available to every researcher. What consistently distinguishes top AOD-9604 vendors is comprehensive lot-matched testing data: HPLC for purity, mass spec for peptide identity confirmation, and endotoxin testing for safety screening. The sections below cover what El Chocolate researchers need to know about finding, evaluating, and storing AOD-9604 for legitimate research applications.
AOD-9604 Mechanisms Explained
The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For El Chocolate researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.
Buying AOD-9604: Quality Markers to Look For
Vetting AOD-9604 vendors begins with the COA: locate the batch-specific certificate before placing an order, not after. Mass spectrometry in the COA establishes that the main HPLC peak is actually AOD-9604 and not another compound with similar chromatographic behaviour — HPLC purity alone provides no identity confirmation. For El Chocolate researchers evaluating vendors with limited track records: a small initial order to verify quality before scaling up your order is the accepted approach among experienced researchers. Bacteriostatic water is the standard reconstitution medium for AOD-9604 — it contains 0.9% benzyl alcohol that suppresses bacterial proliferation and extends reconstituted shelf life to approximately one month when stored at 2-8°C.
Order AOD-9604 — ships to El Chocolate
COA-verified · International tracking · Research grade
All use of AOD-9604 in El Chocolate or anywhere is research use only — this compound is not approved for human therapeutic use, and all handling should follow research laboratory protocols. Lyophilised AOD-9604 should be frozen at −20°C as soon as it arrives; do not freeze and thaw reconstituted AOD-9604 multiple times by preparing small aliquots before storage. Verify the endotoxin level in your AOD-9604 batch COA before use in any in-vivo protocol — look for results expressed as EU/mg or EU/mL and verify they are within the acceptable range for your research context. PubMed and bioRxiv provide the most complete literature coverage for AOD-9604 research; favour indexed journal publications over preprints over unreviewed preprints or forum reports.
Frequently Asked Questions
What is the clinical trial history of AOD-9604?
AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.
What is AOD-9604?
AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.
How does AOD-9604 differ from growth hormone?
AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.
